Lens fluorescence in relation to glucose tolerance and genetic predisposition to type 2 diabetes mellitus in a population-based study

被引:6
|
作者
Koefoed Theil, Pernille
Kessel, Line
Hansen, Torben
Lund-Andersen, Henrik
Pedersen, Oluf
Larsen, Michael
机构
[1] Univ Copenhagen, Glostrup Hosp, Dept Ophthalmol, DK-2600 Glostrup, Denmark
[2] Steno Diabet Ctr, Copenhagen, Denmark
关键词
glucose metabolism; lens fluorescence; screening; type 2 diabetes mellitus;
D O I
10.1080/02713680600850971
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: The fluorescence of the lens has the characteristics of a life-long cumulative index of glycemia, and it is elevated in patients with diabetes in proportion to the duration of diabetes and the level of glycemia. Consequently, lens fluorometry should be capable of providing an estimate of prediagnostic disease duration when patients are diagnosed with type 2 diabetes. Among euglycemic subjects, first-degree relatives of patients with type 2 diabetes tend to have higher glycemia levels than subjects who are unrelated to diabetes patients. They should therefore also have the higher lens fluorescence values. Methods: The study comprised 218 Caucasian subjects in self-reported good health aged 30-88 years who were recruited from population-based studies to represent approximately equal proportions of different type 2 diabetes family history characteristics: no diabetic relative, first-degree offspring, second-degree offspring, not first-degree offspring but possibly second-degree offspring, or uncertain family history. Characterization of subjects included oral glucose tolerance testing and lens fluorometry. Results: Type 2 diabetes was diagnosed in 10 subjects (4.6% of the population) and impaired glucose tolerance in 12 subjects (5.5%). Regression analysis indicated a prediagnostic duration of type 2 diabetes of 2.7 years versus 0.1 years for impaired glucose tolerance. Neither group demonstrated significantly increased lens fluorescence compared with euglycemic subjects. Being a first-degree relative of a patient with type 2 diabetes was associated with higher lens fluorescence than having no relative with diabetes (p = 0.02). Conclusions: Population screening by fasting blood glucose measurement can advance the diagnosis and initiation of treatment of type 2 diabetes mellitus by nearly a decade, compared with previous studies of patients diagnosed in routine clinical practice. In addition to higher than normal glycemia, euglycemic subjects who are offspring of patients with type 2 diabetes also have both elevated lens fluorescence and elevated glycemia. Fasting blood glucose measurement remains the method of choice for type 2 diabetes screening.
引用
收藏
页码:733 / 738
页数:6
相关论文
共 50 条
  • [21] Outdoor light at night, genetic predisposition and type 2 diabetes mellitus: A prospective cohort study
    Xu, Zhihu
    Jin, Jianbo
    Yang, Teng
    Wang, Yuxin
    Huang, Jing
    Pan, Xiaochuan
    Frank, Kelly
    Li, Guoxing
    ENVIRONMENTAL RESEARCH, 2023, 219
  • [22] Cancer incidence in patients with type 2 diabetes mellitus: a population-based cohort study in Shanghai
    Hui-Lin Xu
    Hong Fang
    Wang-Hong Xu
    Guo-You Qin
    Yu-Jie Yan
    Bao-Dong Yao
    Nai-Qing Zhao
    Yi-Nan Liu
    Fen Zhang
    Wei-Xi Li
    Na Wang
    Jie Zhou
    Jin-Ling Zhang
    Li-Yun Zhao
    Lun-Qiang Li
    Yan-Ping Zhao
    BMC Cancer, 15
  • [23] Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study
    Jenny Hernestål-Boman
    Margareta Norberg
    Jan-Hakan Jansson
    Mats Eliasson
    Jan W Eriksson
    Bernt Lindahl
    Lars Johansson
    Cardiovascular Diabetology, 11
  • [24] EFFECTIVENESS OF OSTEOPOROSIS DRUGS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A POPULATION-BASED COHORT STUDY
    Rodrigurez, L. Gomez
    Poveda, J. L.
    Carbonell-Abella, C.
    Reyes, C.
    Gimenez, M. A. Pou
    Torne, C. Diaz
    Martinez-Laguna, D.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S221 - S222
  • [25] Incidence of Bladder Cancer in Type 2 Diabetes Mellitus Patients: A Population-Based Cohort Study
    Pan, Yueh
    Lee, Chia-Yi
    Lee, Liang-Ming
    Wen, Yu-Ching
    Huang, Jing-Yang
    Yang, Shun-Fa
    Hsiao, Chi-Hao
    MEDICINA-LITHUANIA, 2020, 56 (09): : 1 - 10
  • [26] Hospitalization in patients with type 2 diabetes mellitus in Taiwan: A nationwide population-based observational study
    Wang, Jun-Sing
    Wu, Yi-Ling
    Shin, Shyi-Jang
    Tien, Kai-Jen
    Chin, Ming-Chu
    Hwu, Chii-Min
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2019, 118 : S90 - S95
  • [27] Cancer incidence in patients with type 2 diabetes mellitus: a population-based cohort study in Shanghai
    Xu, Hui-Lin
    Fang, Hong
    Xu, Wang-Hong
    Qin, Guo-You
    Yan, Yu-Jie
    Yao, Bao-Dong
    Zhao, Nai-Qing
    Liu, Yi-Nan
    Zhang, Fen
    Li, Wei-Xi
    Wang, Na
    Zhou, Jie
    Zhang, Jin-Ling
    Zhao, Li-Yun
    Li, Lun-Qiang
    Zhao, Yan-Ping
    BMC CANCER, 2015, 15
  • [28] Type 2 diabetes mellitus risk associated with sarcoidosis: A Swedish population-based cohort study
    Entrop, Joshua P.
    Kullberg, Susanna
    Grunewald, Johan
    Brismar, Kerstin
    Arkema, Elizabeth
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [29] Type 2 diabetes mellitus and colorectal cancer risk: A population-based, historical cohort study
    Limburg, P
    Vierkant, R
    Fredericksen, Z
    Leibson, C
    Melton, LJ
    Rizza, R
    Gupta, A
    Ahlquist, D
    Sellers, T
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S121 - S121
  • [30] Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study
    Hernestal-Boman, Jenny
    Norberg, Margareta
    Jansson, Jan-Hakan
    Eliasson, Mats
    Eriksson, Jan W.
    Lindahl, Bernt
    Johansson, Lars
    CARDIOVASCULAR DIABETOLOGY, 2012, 11